In a powerful Wall Street Journal essay, retired internal-medicine physician Brent Beasley recounts how he discovered—almost by accident—that he had Alzheimer’s disease at age 57. His story is not just personal. It is an indictment of a U.S. health care system that waits for crisis instead of preventing it. Beasley Read more…
Independent federal agencies were a hallmark of the Progressive Era, designed to operate at arm’s length from elected officials. Over time, however, many of these agencies have accumulated powers that raise serious constitutional concerns—writing rules, enforcing them, and adjudicating disputes internally. In a recent RealClearMarkets piece, Charles Sauer argues that Read more…
In a recent RealClearMarkets article, Charles Sauer uses a football analogy to capture what’s at stake in today’s antitrust debates. Football works because the rules are known in advance and applied consistently. When referees invent new rules mid-game, the integrity of competition collapses. Markets operate the same way. Sauer argues Read more…
President Trump recently floated the idea of imposing a one-year cap on credit card interest rates at 10 President Trump recently floated the idea of imposing a one-year cap on credit card interest rates at 10 percent. Given that Americans currently hold more than $1.2 trillion in credit card debt—and Read more…
The Market Institute is proud to have signed onto a coalition letter supporting the Recycling Technology Innovation Act (H.R. 6566), bipartisan legislation that would provide regulatory certainty for advanced recycling technologies and bring federal policy in line with market realities. Advanced recycling plays an increasingly important role in modern manufacturing Read more…
As Congress debates whether to extend the Affordable Care Act’s enhanced insurance subsidies—originally enacted as part of the 2021 COVID relief bill—lawmakers face a familiar dilemma: preserve a failing system through temporary fixes or pursue reforms that empower patients and lower costs in the long run. In a recent article Read more…
In a recent RealClearMarkets column, Charles Sauer explains why Netflix’s proposed acquisition of Warner Bros. should be approved—and why it highlights the failure of outdated antitrust thinking in a fast-moving entertainment market. Netflix appears poised to acquire Warner Bros. despite a hostile takeover bid from Paramount Pictures. While the deal Read more…
In a recent RealClearMarkets column, Norm Singleton pushes back against the familiar panic that accompanies every major technological shift in the movie industry—this time aimed at streaming and Netflix’s proposed acquisition of Warner Brothers. Singleton reminds readers that resistance to innovation is nothing new. From the earliest days of sound Read more…
This month, the Alzheimer’s Policy Working Group (APWG) released a new policy paper, Solving America’s Alzheimer’s Challenge, laying out a clinician-driven roadmap to improve how the U.S. diagnoses and manages Alzheimer’s disease—starting in primary care, where most patients first raise concerns. The paper reflects the real-world experience of frontline physicians Read more…
In a recent RealClearMarkets column, Charles Sauer examines the growing push to impose “most favored nation” (MFN) drug pricing through legislation expanding access to home infusion therapy—and explains why importing foreign-style price controls would ultimately hurt patients, not help them. Home infusion therapy allows millions of Americans with cancer, heart Read more…